Press Releases

CANet > Newsroom > Press Releases
In The Beat Newsletter

Sign up for the CANet monthly newsletter to stay informed with our Networks activities.

Media Inquiries

Fabian Folias Director of Digital Marketing and Communications media@canet-nce.ca 519-661-2111 x81353   

We are pleased to match Baylis’ investment to accelerate the development and commercialization of the first-in-Canada medical devices that will be used by doctors during heart procedures. Such innovative and transformative products are expanding international markets for made-in-Canada technologies that have a positive impact on patients around the world.

Honourable Navdeep Bains
Minister of Innovation, Science and Economic Development and Minister, FedDev Ontario

Media Releases

Important Announcements

12
May

CANet will receive Networks of Excellence of Canada (NCE) renewed federal funding totalling $15.7 million

London, ON, May 12, 2020 ⁠— CANet is pleased to announce its renewed federal funding of $15.7 million over three years (totalling $42 million for 2014-23) from the Networks of Excellence of Canada (NCE). With over $46+ million in matching funds from partners to date, this support will enable our network to continue its digital...
Read More
11
May

Cardiac Arrhythmia Network of Canada (CANet) funded study provides virtual care link to Remote Patient Management for Cardiac Implantable Electronic Devices with VIRTUES

Halifax, NS, May 11, 2020 – Remote Patient Management for Cardiac Implantable Electronic Devices (RPM-CIED), a national randomized controlled study, consisting of over two-thousand patients in 12 sites across Canada, has launched in Calgary, AB, Halifax, NS, Kitchener, ON, and Quebec City, QC. This program focuses on patient care with remote management of implantable cardiac...
Read More
16
Dec

CANet® is proud to announce the inaugural ‘Shift – Heart Rhythm Innovation Competition’

Toronto ON, December 16, 2019 – With the Cardiac Arrhythmia Network of Canada (CANet®) group of investigators leading ground-breaking arrhythmia health research and technology advancements, our Network is challenging startups to highlight their innovations at the inaugural CANet® Shift competition. Here’s your opportunity to showcase your innovation and win $200,000! Canadian health technology startups will...
Read More
05
Nov

Randomized Controlled Trial Finds NRG® Transseptal Needle Leads to Shorter Procedure Times, Reduced Radiation Exposure

TORONTO, NOVEMBER 5, 2019 – A randomized controlled trial has found that use of Baylis Medical’s NRG® Transseptal Needle results in shorter time in achieving transseptal access, less transseptal attempts, and reduced exposure to radiation, compared to use of a conventional transseptal needle. The study, entitled Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture...
Read More
01
Feb

CANet VIRTUES: cutting-edge technology ushers in a bold new era of arrhythmia care

London, ON, February 1, 2019 — Cardiac Arrhythmia Network of Canada (CANet) leverages cutting edge technology to empower its patients. Digital innovations like artificial intelligence, blockchain technology, and consumer-grade wearables are now mainstream. Healthcare services must invest in these breakthroughs to deliver better medical care for Canadians. CANet is currently focusing on solutions – advanced...
Read More